Molecular Medicine Partnership Unit Medical Campus of the University of Heidelberg, Germany. Research themes place emphasis on common diseases, particularly blood disorders, cancer, iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS. In 2018 more than 110 scientists from across the world work on these eight research themes: Molecular Medicine Partnership Unit The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies. Founded in
Paget's disease of bone clinical manifestation of Paget's disease is usually an elevated alkaline phosphatase in the blood. Paget's disease may be diagnosed using one or more of the following tests: Although initially diagnosed by a primary care physician, endocrinologists (internal medicine physicians who specialize in hormonal and metabolic disorders), rheumatologists (internal medicine physicians who specialize in joint and muscle disorders), orthopedic surgeons, neurosurgeons, neurologists, oral and maxillofacial surgeons, and otolaryngologists are generally knowledgeable about treating Paget's disease, and may be called upon to evaluate specialized symptoms. It can sometimes difficult to predict whether a person with Paget's disease, who otherwise has no signs